On February 26, 2020 Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, reported it will present at the Cowen & Co. 40th Annual Health Care Conference on Monday, March 2, 2020 in Boston, Massachusetts and the 30th Annual Oppenheimer Healthcare Conference on Wednesday, March 18, 2020 in New York (Press release, Cue Biopharma, FEB 26, 2020, View Source [SID1234608304]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details can be found below:

Cowen Health Care Conference
Date and Time: Monday, March 2 at 2:10 p.m. EST
Location: Boston Marriott Copley Place
A live and archived version of the webcast will be available at http://wsw.com/webcast/cowen57/cue/. The presentation will be archived for 30 days on the Investors section of the Company’s website at www.cuebiopharma.com.

Oppenheimer Healthcare Conference
Date and Time: Wednesday, March 18 at 9:10 a.m. EDT
Location: InterContinental Barclay Hotel (Grand Ballroom 1)
The webcast link will be available on the Cue Biopharma website two weeks prior to this event. The presentation will be archived for 30 days on the Investors section of the Company’s website at www.cuebiopharma.com.